Mast cells contribute to the modulation of the immune response, but their role in autoimmune renal disease is not well understood. Here, we induced autoimmunity resulting in focal necrotizing GN by immunizing wild-type or mast cell-deficient (Kit W-sh/W-sh ) mice with myeloperoxidase. Mast cell-deficient mice exhibited more antimyeloperoxidase CD4+ T cells, enhanced dermal delayed-type hypersensitivity responses to myeloperoxidase, and more severe focal necrotizing GN. Furthermore, the lymph nodes draining the sites of immunization had fewer Tregs and reduced production of IL-10 in mice lacking mast cells. Reconstituting these mice with mast cells significantly increased the numbers of Tregs in the lymph nodes and attenuated both autoimmunity and severity of disease. After immunization with myeloperoxidase, mast cells migrated from the skin to the lymph nodes to contact Tregs. In an ex vivo assay, mast cells enhanced Treg suppression through IL-10. Reconstitution of mast cell-deficient mice with IL-10-deficient mast cells led to enhanced autoimmunity to myeloperoxidase and greater disease severity compared with reconstitution with IL-10-intact mast cells. Taken together, these studies establish a role for mast cells in mediating peripheral tolerance to myeloperoxidase, protecting them from the development of focal necrotizing GN in ANCA-associated vasculitis.
Mast cells (MCs) have the potential to participate in diverse roles in the immune system. In addition to their well characterized effector role in IgEmediated allergic inflammation, MCs are now recognized as mediators of host antimicrobial defense, and they play injurious roles in many models of chronic human diseases. In innate immunity, MCs, by virtue of their tissue distribution in mucosal and dermal surfaces together with their array of preformed and synthesized mediators (including TNF, IL-1a, IL-1b, IL-6, and leukotrienes), act as sentinels and first responders in host defense. 1 Additionally, MCs can participate in the generation of adaptive immunity. 2 Several MC products, such as histamine and the cytokines IFNg, IL-4, IL-6, and TGF-b1, can activate T cells and influence the polarization of T helper cell subset differentiation. 3 Emerging evidence also confirms a role for MC in inducing immunoregulation. MCs have amongst their capabilities the capacity to express cell surface immunomodulatory molecules, including both TNF receptor (OX40L and 4-1BB) and B7 family members (PD-L1), 4, 5 and synthesize anti-inflammatory mediators, such as IL-10. 6 Studies in ultraviolet B-induced immunosuppression of contact hypersensitivity and mosquito bite-induced immunosuppression of delayed type hypersensitivity (DTH) have highlighted the importance of MCderived IL-10 in mediating immune regulation. [7] [8] [9] MCs have been shown to participate, together with Tregulatory cells (Tregs), in the maintenance of skin graft tolerance and in a model of glomerular inflammation induced by immunity to a foreign protein planted in glomeruli. 10, 11 Both studies highlight the importance of IL-9 (a known MC growth factor potentially made by Tregs) in facilitating MC immunomodulation.
The presence of MCs in diseased organs in many human autoimmune diseases has suggested that these cells may participate in the associated immunopathology. The role of MCs in autoimmunity has been assessed in several well characterized animal models of human disease. 12 These studies use the availability of MC-deficient Kit W/Wv or Kit W-sh/W-sh mice. This MC deficiency phenotype results from a number of different mutations in c-Kit or its signaling pathway associated with the failure of MC lineage development. 13 Although the first strain to be widely used was the Kit W/Wv strain, these mice have important phenotypic abnormalities beyond the absence of MCs, and therefore, this strain may not be optimal for determining the functional role of MCs. 14 However, other strains, including Kit W-sh/W-sh mice used in the current experiments, do not have major extra MC phenotypic abnormalities other than the deficiency of MC, and they are the preferred strain to observe the functional role of MCs. The standard proof in defining a role for MCs is to show a change in disease severity in MC-deficient mice and then confirm that the change in disease outcome is dependent specifically on MCs by showing that MC reconstitution restores disease severity. 1 As summarized in a recent comprehensive review, experimental models of autoimmunity almost entirely show proinflammatory roles for MCs in diseases models (including bullous pemphigus, systemic sclerosis, type 1 diabetes mellitus, and rheumatoid arthritis). 12 In experimental autoimmune encephalomyelitis, a widely studied model, there is no consensus as to the role of MCs. [15] [16] [17] GN is one of the major causes of end stage renal failure worldwide, and thus, it constitutes a major burden of human disease. The most common form of rapidly progressive GN is caused by antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (AAV). AAV has an autoimmune basis, involving T and B cell autoreactivity to neutrophil lysosomal enzymes proteinase-3 and myeloperoxidase (MPO), resulting in the development of focal necrotizing GN. Proof that immunity to MPO can induce GN comes from elegant studies generating immunity to MPO in MPO-deficient (2/2) mice and inducing GN in Rag2/2 mice by splenocyte transfer. 18 MPO autoimmunity can also be induced in susceptible mouse strains by immunizing C57BL/6 mice with murine MPO. Planting MPO in the glomeruli of these mice with established systemic autoimmunity induces GN through autoreactive MPO-specific CD4+ effectors. 19 MCs have been found in increased numbers in affected kidneys correlating with disease severity, suggesting their potential role in AAV, 20 although to date, no functional data have been provided to test this hypothesis. In these studies, we used MCdeficient and MC-reconstituted Kit W-sh/W-sh mice to demonstrate that, in the induction of autoimmunity to MPO, MCs migrate to draining lymph nodes (LNs), where they interact with Tregs. These interactions regulate autoimmunity and diminish the severity of subsequently induced anti-MPO-mediated GN. Studies with IL-102/2 MC ex vivo and in vivo show that MC production of IL-10 is responsible for this immunomodulation.
RESULTS

Renal Injury and Systemic Autoimmunity to MPO in MC Deficient Kit
Wsh/Wsh Mice Developing Anti-MPO-Induced Glomerulonephritis To induce experimental anti-MPO GN in C57BL/6 mice, autoimmunity to MPO was established; then, GN was triggered by injecting a subnephritogenic dose of antiglomerular basement membrane (GBM) antibody to recruit and degranulate neutrophils, thereby depositing MPO in the glomerular capillary bed. This process results in the accumulation of MPO-specific CD4+ cells that direct DTH type effectors. Over 4 days, GN develops and resembles glomerular lesions observed in human AAV. In this model, the subnephritogenic dose of anti-GBM antibody does not contribute directly to injury except by facilitating neutrophil influx and MPO release. Previously published controls involving this anti-GBM antibody and this dose included administration to ovalbuminimmunized wild-type mice as well as MPO-immunized MPO2/2 mice. These mice did not develop GN. 19, 21 MPO-immunized Kit W-sh/W-sh mice induced with anti-MPO GN showed enhanced renal injury with increases in focal glomerular necrosis ( Figure 1, A and B) , fibrin deposition (Figure 1 , C and D), and proteinuria ( Figure 1E ) compared with MC-intact C57BL/6 mice. Analyses of cellular effectors of renal damage revealed greater numbers of glomerular CD4+ T cells and macrophages in Kit W-sh/W-sh mice. Although glomerular neutrophil accumulation was not significant, there was a trend to increased neutrophil numbers in Kit W-sh/W-sh mice ( Figure 1F ). Systemic autoimmunity was assessed by measuring dermal DTH to MPO, MPO cytokine recall responses, and proliferation of cells isolated from LNs draining the site of MPO immunization. Development of MPO autoimmunity was observed in both C57BL/6 and C57BL/6 Kit W-sh/W-sh mice. T cell-mediated immune responses were significantly enhanced in Kit W-sh/W-sh mice, and they were confirmed by increased MPO-specific dermal DTH swelling ( Figure 1G ) and increased proliferation by in vitro thymidine incorporation (Figure 1H ) and IL-17A production ( Figure 1I ) compared with wild-type mice. Conversely, the percentage of foxp3+CD4+ cells and the production of IL-10 by draining LN cells was reduced in Kit W-sh/W-sh mice ( Figure 1 , J and K). Humoral immunity measured by ELISA for anti-MPO antibody (ANCA) was similar in both groups (Supplemental Figure 1A) .
Reconstitution of Kit
Wsh/Wsh Mice with MCs To confirm that the increased autoimmunity observed in Kit W-sh/W-sh mice was caused by their MC deficiency, in (Figure 2 , A and B and Supplemental Figure 2 ) and less fibrin deposition ( Figure 2C ) and proteinuria ( Figure 2D ). Infiltrating glomerular DTH effector leukocytes, neutrophils, macrophages, and CD4+ cells were also reduced in MC-reconstituted Kit W-sh/W-sh mice ( Figure  2E ). Systemic autoimmunity, assessed by dermal DTH swelling to MPO, was significantly reduced by MC reconstitution ( Figure 2F ). Similarly, MPO challenge of LN cells from draining immunization sites showed less MPO-induced cell proliferation and reduced IL-17A production in MC-reconstituted Kit W-sh/W-sh mice ( Figure 2 , G and H). The percentage of CD4+ LN cells that expressed foxp3 was also elevated by MC reconstitution ( Figure 2I ). Similar to a previous experiment, ANCA titers were similar between reconstituted and nonreconstituted Kit W-sh/W-sh mice (Supplemental Figure 1B ).
MCs Migrate from Sites of MPO Presentation to Draining LN
Six days post-MPO immunization, draining LNs from MCintact WT mice were examined to explore the involvement of MC participation in the cellular events inducing and regulating autoimmunity. There was a fourfold increase in MC numbers at this time in LN draining sites of MPO immunization compared with nonimmunized WT mice ( Figure 3 , A-C). We then used immunostaining of Tregs using the Treg-specific transcription factor, foxp3, and MCs using cell surface marker c-Kit and confocal microscopy to assess potential MC and Treg interaction. Frequent intimate contact between MCs and Tregs, particularly in the subcapsular region of LNs, was observed ( Figure 3D ).
MC Immunomodulation of MPO Autoimmunity Is Dependent on MC IL-10
To explore the mechanisms of MC-dependent immunoregulation, we established an ex vivo cell coculture system using foxp3-GFP (green fluorescent protein expressing) mice. Anti-MPO autoimmunity was induced in foxp3-GFP mice by MPO immunization; after 10 days, draining LNs were isolated, and populations of effector T cells (Teffs; CD4+foxp32) and Tregs (CD4+foxp3+) were separated. By varying the ratios of these cells in an MPO recall assay, we showed a dose-response effect of Tregs on MPO recall responses by Teffs ( Figure 4A ). We found that culturing Teffs with wild-type MCs did not diminish recall responses to MPO ( Figure 4B ), whereas the addition of wild-type MCs to Treg enhanced their capacity to inhibit Teff proliferative responses to MPO in an IL-10-dependent manner ( Figure 4C ). Furthermore, Tregs in the presence of wild-type MCs decrease MPO Teff capacity to produce proinflammatory cytokines (IFNg, IL-17A, and IL-6), and this production is also dependent on MC IL-10 ( Figure 4 , D-F).
In Vivo MC Immunomodulation of MPO Autoimmunity and Renal Injury Is Dependent on MC IL-10
We hypothesized that IL-10 was a likely effector of MC immunomodulation for two reasons. Previous studies, albeit in nonautoimmune models, have shown that MC IL-10 can account for immunomodulation. 7, 8 Our study shows that IL-10 levels were reduced in draining LNs of MC-deficient mice, showing enhanced MPO autoimmunity ( Figure 1J ). We, therefore, reconstituted Kit W-sh/W-sh mice with either IL-102/2 or IL-10+/+ (wild-type) MCs and compared the development of anti-MPO autoimmunity and renal injury in experimental autoimmune anti-MPO GN. Successful reconstitution of Kit W-sh/W-sh mice was verified after completion of the experiment by immunohistological staining LN MCs and genotyping splenic MCs. We found that wild-type MCreconstituted Kit W-sh/W-sh mice were protected from glomerular injury compared with IL-102/2 MC-reconstituted mice. The extent of focal glomerular necrosis ( Figure 5 , A and B), fibrin deposition ( Figure 5C ), and proteinuria ( Figure 5D ) was significantly less. Glomerular infiltration of leukocytes was also reduced ( Figure 5E ). Systemic autoimmunity to MPO was attenuated, which was shown by the reduction in MPOinduced dermal DTH ( Figure 5F ), a reduction in the extent of MPO recall-induced draining LN cell proliferation ( Figure 5G ), and decreased frequency of IL-17A producing CD4+ T cells ( Figure 5H ). The percentage of CD4+foxp3+ Tregs in the draining nodes was significantly elevated compared with the percentage observed in Kit W-sh/W-sh mice reconstituted with IL-102/2 MCs ( Figure 5I ).
DISCUSSION
MCs have been observed to play proinflammatory roles in most of the experimental immune disease models in which they have been studied. 12, 23 However, several studies suggest that MCs can also play a role in immune regulation. These studies include UV-induced skin damage, 7,24 mosquito biteinduced DTH immune responses, 8 and graft tolerance. 10, 25 These models also highlight the ability of MCs to produce molecules that may attenuate injurious adaptive immune responses, including TGF-b, IL-10, IL-4, granzyme B, and perforin, and they may express surface receptors (OX40L) that facilitate immunoregulation after direct contact with regulatory cells. 1, 26 The role of MCs in autoimmunity has been assessed in a number of animal models of human diseases using MC-deficient mice. The overwhelming outcome has been to suggest that MCs play a proinflammatory injurious role. 12 Unexpectedly, we found that MPO-immunized Kit W-sh/W-sh mice developed enhanced functional (proteinuria) and structural (glomerular; necrosis, fibrin deposition, and leukocyte accumulation) renal injury compared with MPO-immunized wild-type mice. MPO-immunized Kit W-sh/W-sh mice developed enhanced MPO autoimmunity (measured by dermal DTH responses to MPO) as well as elevated systemic CD4+ anti-MPO responses of MPO-specific cell proliferation and increased production of IL-17A from MPO-stimulated lymphocytes isolated from draining LNs compared with wild-type controls.
No difference in the IFNg levels was observed between groups (data not shown). We have previously shown that, in autoimmune anti-MPO GN, CD4+ Th17 cells are important in inducing these injurious cell-mediated effector responses. 21, 27 Taken together, the increased autoimmunity to MPO and intensity of MPO-triggered disease suggest a cause and effect relationship. Development of humoral immunity was unaltered between groups. The current model used is T celldependent and does not allow for an extensive development of the B cell response, in which MPO-immunized mchain2/2 mice still develop GN. 19 On day 16, a difference in ANCA titers was not detected (Supplemental Figure 1) . Differences in titers are more likely to be detected at later stages in the development of autoimmunity. We believe that one of the roles of ANCA is to facilitate glomerular MPO deposition by inducing neutrophil recruitment. However, in this model, disease is triggered by passive deposition of neutrophils using a subnephritogenic dose of anti-GBM antibody. Furthermore, to confirm that the subnephritogenic dose of anti-GBM antibody does not elicit overt injury beyond its role in neutrophil recruitment and MPO deposition in Kit W-sh/W-sh mice, we administered the standard triggering doses of anti-GBM antibody to wild-type and Kit W-sh/W-sh mice immunized with an irrelevant antigen, ovalbumin. Kit W-sh/W-sh mice did not show increased injury. Levels of proteinuria were not different and were both similar to protein excretion in wild-type mice (not given anti-GBM antibodies) (Supplemental Figure 3) .
To verify that the protective effects observed in Kit W-sh/W-sh mice are a result of its MC deficiency and not related to other potential c-Kit abnormalities, MC reconstitution of C57BL/6 Kit W-sh/W-sh mice was subjected to autoimmune anti-MPO GN. Reconstitution of Kit W-sh/W-sh mice resulted in attenuated systemic anti-MPO autoimmunity associated with significant reduction in consequent functional and morphologic glomerular injury, and it was similar to disease outcome in MPO-immunized wild-type mice. The observed enhanced autoimmunity and increased glomerular injury in MCdeficient mice, together with the capacity for MC reconstitution to diminish anti-MPO autoimmunity and the severity of GN in Kit W-sh/W-sh mice, strongly suggest that MCs are critical in protecting mice from the development of anti-MPO autoimmunity and consequently, the severity of GN. Furthermore, the ability of purified MCs to reduce the intensity of autoimmunity and renal injury in Kit W-sh/W-sh mice strongly supports the role of MCs in immunomodulation in this disease model and not other potential MC-independent c-Kit dependent factors. This line of proof of MC function is the accepted standard when using these mice to confirm that the biologic abnormalities observed in Kit W-sh/W-sh mice are induced by MCs. 1 Our attention was focused on the potential involvement of MCs in the LN draining the site of MPO immunization was used to find evidence consistent with MC participation in the cellular events inducing and regulating autoimmunity. Previous studies have shown that MCs can migrate to nodes at the time of antigen presentation and that the migration is directed by the CXCR4/CXCL12 chemokine pathway. 9, 28, 29 From this information, we examined the migratory pattern of MCs in MPO-immunized and nonimmunized MC intact wild-type mice. There was a fourfold increase in the number of MCs observed in the draining LNs of MPO-immunized mice compared with nonimmunized wild-type mice, and confocal immunofluorescence imaging of these nodes revealed that MCs reside in close proximity with foxp3+ Tregs. These observations provide evidence consistent with a role for MCs in Treg immunomodulation of developing MPO autoimmunity. Such contact between Tregs and MCs has been shown in the draining LN of experimental skin allografts, where MC and Treg interaction functionally underpins immunoregulation in allogeneic responses, promoting graft tolerance. 10, 25 To date, the most clearly shown mechanism of MC immunomodulation is MC production of IL-10. 6, 30 In the current study, we found significantly lower levels of IL-10 in LN cells from MC-deficient Kit W-sh/W-sh mice associated with enhanced anti-MPO autoimmunity compared with wild-type mice ( Figure 1J ). This finding raised the possibility that MC IL-10 could mediate the observed immunosuppression. The observed interaction between MCs and Tregs in LNs was also consistent with local MC-produced IL-10 reducing recall MPO-induced proliferation of autoimmune anti-MPO CD4+ cells. This hypothesis was supported by the ex vivo studies, where MC coculture with Tregs attenuated both the proliferation of anti-MPO CD4+ cells and the production of proinflammatory cytokines. Both these effects were dependent of MC IL-10 production. These results support the findings that MCs in vivo act as immunomodulators of anti-MPO autoimmunity.
Proof of the functional capacity of MC-derived IL-10 in attenuating the development of autoimmune anti-MPO GN was achieved by reconstituting Kit W-sh/W-sh mice with either W-sh/W-sh mice also developed increased proinflammatory anti-MPO CD4+ responses (MPO recall cell proliferation and IL-17A) and a decrease in the proportion of draining LN CD4+ Tregs. Taken together with the ex vivo coculture experiment, these results show that immunomodulation of autoimmune anti-MPO GN occurs through MC-derived IL-10.
MCs are characterized by the pleiotropic functional capacities and their ability to become variably involved in potentially paradoxical outcomes by minor differences in activation brought about by differences in the balance of local environmental signals that they receive. 31 Thus, as well as immunomodulation, MCs can enhance immune development, facilitate leukocyte recruitment, and mediate injury by assisting the development of immune effector responses. 22, 32 It is possible that MCs may be making such contributions in the current experiments. However, the power of whole-animal studies is the capacity to assess the net effect of all the contributions that MCs may be making. In autoimmune anti-MPO vasculitis and GN, the overall effect of MCs is significant enhancement of peripheral tolerance and protection from the development and severity of autoimmunity and disease.
In conclusion, this study supports a role for MCs in the immunoregulation of induced autoimmunity to MPO, thereby limiting the severity of GN directed by autoimmune anti-MPO effector cells. This study provides evidence that MCs are involved in the closely orchestrated network of events that maintains peripheral tolerance, thus protecting from the development of autoimmunity. The suggestion that MCs may play such an immunoregulatory role has led to the hypothesis that MC immunosuppressor cells may exist. 26 Distinct subpopulations of such regulatory subsets of other leukocyte populations have been phenotypically shown (M2 macrophages and N2 neutrophils). 33, 34 MC biology emphasizes the plasticity of MCs responding in different ways (pro-or anti-inflammatory) according to the net effect of signals that they detect from their environment. Thus, acquisition of immunoregulatory phenotypes of MCs could be considered as the development of a new MC regulatory subpopulation.
CONCISE METHODS
Mice
C57BL/6 (wild-type) male mice (n=8-10 per group) were purchased from Monash University Animal Services (Melbourne, Australia), and age-and sex-matched MC-deficient C57BL/6 Kit W-sh/W-sh mice (n=8-10 per group) were purchased from Jackson Laboratories (Bar Harbor, Connecticut, MA). IL-102/2 C57BL/6 male mice, purchased from the University of Adelaide (South Australia, Australia,) and originally from Jackson Laboratories, were used as donors to obtain bone marrow MCs. Foxp3-GFP mice 35 
MC Reconstitution
Kit W-sh/W-sh mice were reconstituted with MCs using a standard in vitro differentiation of MCs technique. 13, 22 Briefly, bone marrow cells were harvested from 6 to 8 week old wild-type or IL-102/2 mice. Cells were cultured in RPMI supplemented with 15% FCS, 1% Pen/ Strep, 2 mM L-glutamine, 1 mM sodium pyruvate (Invitrogen, Melbourne, Australia), 50 mm 2-mercaptoethanol (Sigma-Aldrich), IL-3 (obtained from WEHI3 cell culture supernatants), and 12.5 ng/ml recombinant mouse stem cell factor (R&D Systems, Minneapolis, MN). Nonadherent cells were transferred into fresh culture media every 3 days for [6] [7] [8] Fibrin staining was performed on 3-mm-thick paraffin-cut sections using rabbit anti-mouse fibrinogen (R-4025; a gift from Dr. J. Degen, Childrens Research Foundation, Cincinnati, OH) with an ABC kit (Dako-Cytomation, Glostrup, Denmark) using 3,39-diaminobenzidine (Sigma-Aldrich) as a substrate. 38 A minimum of 40 glomeruli per mouse was scored, and results were expressed as the percentage of glomeruli with fibrin deposition.
Proteinuria was assessed by housing mice in individual cages to collect urine over the final 24 hours of each experiment. Urinary protein was measured by modified Bradford's method using Bradford's reagent (Page Blue G-90 [Sigma-Aldrich)], 85% orthophosphoric acid [Ajax Finechem, Australia] in distilled water) and calculated from the 24-hour urine volume and the urinary protein concentration (milligrams per 24 hours). 39 Urine creatinine concentrations were measured by an enzymatic creatininase assay using standard laboratory methods at Monash Medical Centre. Both protein concentration and creatinine units were converted to milligrams per milliliter, and results are expressed as a ratio of protein to creatinine.
Assessment of Immune Cells in Kidney and LNs
Glomerular leukocytes (neutrophils, macrophages, and CD4+ T cells) were assessed by an immunoperoxidase-staining technique. Periodate lysine paraformaldehyde frozen 6-mm cryostat-cut kidney sections were stained using a three-layer immunoperoxidase technique as previously described. 40 The primary antibodies used were RB6-85C for neutrophils (anti-GR-1; DNAX, Palo Alto, CA), FA/11 for macrophages (anti-mouse CD68; provided by Dr. G. Koch, MRC, Cambridge, England), and GK1.5 for CD4+ T cells (anti-CD4; American Type Culture Collection, Manassas, VA). The secondary antibody used was rabbit anti-rat biotin (BD Bioscience, North Ryde, Australia) followed by tertiary antibody swine anti-rabbit horseradish peroxidase (DAKO-Cytomation). A minimum of 40 glomeruli per mouse was scored, and results were expressed as positive cells per glomerular cross-section (c/gcs).
LN draining sites of MPO immunization were fixed in Carnoy's solution (60% ethanol, 30% chloroform; Merck, Darmstadt, Germany) and 10% glacial acetic acid (Thermo Fisher Scientific, Waltham, MA) for 18 hours and embedded in paraffin (BDH Laboratory Supplies, Poole, England). For assessment of MC numbers, 3-mm cut sections were stained using toluidine blue. For MC/Treg interactions, sections of paraffin-embedded Carnoy's fixed tissue were treated with antigen retrieval (microwave oven heating in 0.1 M sodium citrate, pH 6, for 20 minutes) followed by immunofluorescence staining for foxp3 and c-Kit using a Vectastatin Elite ABC kit (Vector Burlingame, CA). Sections were blocked (10% rabbit serum, 10% FCS, 5% BSA/ PBS) and then incubated with 4 mg/ml anti-mouse foxp3 (FJK-16s; eBiosciences, San Diego, CA) in 5% rabbit and mouse serum. Endogenous peroxidase activity was ablated by incubation with 0.3% hydrogen peroxidize (Thermo Fisher Scientific) in methanol for 20 minutes and then treated with avidin/biotin blocking solution. Secondary antibody (biotin-conjugated rabbit anti-rat Ig [DAKOCytomation] with 5% sheep and mouse serum) was then incubated with the ABC kit. Sections were then incubated with 4 mg/ml c-Kit conjugated to PE fluorochrome (2B8; BD Biosciences PharMingen), and Sudan black was used to minimize autofluorescence. Images were acquired using a Nikon C1 confocal laser scan head attached to a Nikon Ti-E inverted microscope; 488-and 561-nm lasers were used to specifically excite Alexa488 and Alexa568 flurophores, respectively. Single-plane 5123512312-bit images were captured in a line sequential manner (three-line average) using a 2030.75 NA objective with the pinhole set at 1.0 AU.
Systemic Immune Responses to MPO
To assess DTH responses to MPO, mice were challenged with 10 mg murine MPO in 40 mL saline (Baxter, New South Wales, Australia) in the right hind footpad, whereas the left hind footpad received saline 24 hours before euthanasia. The difference in the swelling between the right and left footpad 24 hours later was measured using a micrometer and represented the degree of DTH to MPO (Δmm). Measurement of circulating anti-mouse MPO IgG titers in sera was measured by ELISA as previously described. 21 For in vitro measurement of MPO-specific cell proliferation, inguinal and para-aortic draining LNs were harvested aseptically from experimental mice and single-cell suspensions prepared in RPMI/ 10% FCS (JRH, KS). Cells were seeded at 5310 5 were cultured with 10 mg/ml MPO in 48-well plates for 72 hours. IL-10 and IL-17A in supernatants were measured by ELISA. Concentrations of IL-10 were measured using rat anti-mouse IL-10 capture antibody (18141D; BD Pharmingen, San Diego, CA), recombinant mouse IL-10 standards (18141D; BD Pharmingen), and biotinylated rat anti-mouse IL-10 detection antibody (BD Pharmingen). IL-17A was measured using paired antibodies (DuoSet; eBioscience).
Assessment of MC Capacity to Enhance Treg Cell Modulation of Anti-MPO CD4+ T Effector Recall Responses
Foxp3-GFP mice (n=5) were immunized with MPO in Freund's adjuvant, and after 10 days, draining LNs were harvested. CD4+ cells were isolated by magnetic cell sorting according to the manufacturer's instructions (MACS CD4+ T Cell Isolation Kit; Miltenyi Biotec, North Ryde, Australia 
